What is Acadia Pharmaceuticals's common stock?

Acadia Pharmaceuticals (ACAD) reported common stock of $16K in Q1 2026.

How has Acadia Pharmaceuticals's common stock changed year-over-year?

Acadia Pharmaceuticals's common stock decreased by 0.0% year-over-year, from $16K to $16K.

What is the long-term trend for Acadia Pharmaceuticals's common stock?

Over 5 years (2020 to 2025), Acadia Pharmaceuticals's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $16K to $16K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Acadia Pharmaceuticals ACAD Common Stock

Common Stock at other companies

BiogenBIIB

$100K0.0%

Neurocrine BiosciencesNBIX

220M0.0%

Catalyst PharmaceuticalCPRX

$122K0.0%

PTC TherapeuticsPTCT

$81K+3.8%

BridgeBio PharmaBBIO

500M+253,707%

TG TherapeuticsTGTX

$160K+0.6%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's common stock?: Acadia Pharmaceuticals (ACAD) reported common stock of $16K in Q1 2026.
How has Acadia Pharmaceuticals's common stock changed year-over-year?: Acadia Pharmaceuticals's common stock decreased by 0.0% year-over-year, from $16K to $16K.
What is the long-term trend for Acadia Pharmaceuticals's common stock?: Over 5 years (2020 to 2025), Acadia Pharmaceuticals's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $16K to $16K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).